3α-hydroxylup-20(29)-en-23,28-dioic acid | 132339-62-9

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 英文名称: 3α-hydroxylup-20(29)-en-23,28-dioic acid
• 英文别名: 3α-hydroxy-lup-20(29)-ene-23,28-dioic acid；3alpha-Hydroxylup-20(29)-ene-23,28-dioic acid；(1R,3aS,5aR,5bR,7aR,8S,9R,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,11a-tetramethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-3a,8-dicarboxylic acid
• CAS: 132339-62-9；83725-39-7
• 化学式: C₃₀H₄₆O₅
• 分子量: 486.692
• InChiKey: NSLGONDVJPFEEN-JOPFMIIHSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  7.5
• 重原子数：
  35
• 可旋转键数：
  3
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.87
• 拓扑面积：
  94.8
• 氢给体数：
  3
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  3α-hydroxylup-20(29)-en-23,28-dioic acid 在 lithium aluminium tetrahydride 作用下， 以 四氢呋喃 、 吡啶 、 甲醇 为溶剂， 反应 130.0h， 生成 3-deoxy-2,3-dehydrolupeol
  参考文献：
  名称：

  3α-Hydroxy-lup-20(29)-ene-23,28-dioic acid from Schefflera octophylla

  摘要：

  DOI：

  10.1016/0031-9422(82)80147-7
• 作为产物：
  描述：

  3α-hydroxy-lup-20(29)-ene-23,28-dioic acid 28-O-[α-L-rhamnopyranosyl(1→4)-O-β-D-glucopyranosyl(1→6)]-β-D-glucopyranoside 在 氢氧化钾 作用下， 以 甲醇 为溶剂， 反应 3.0h， 以33 mg的产率得到3α-hydroxylup-20(29)-en-23,28-dioic acid
  参考文献：
  名称：

  来自鹅掌楸的三萜糖苷

  摘要：

  除了 3-epi-桦木酸外，还从鹅掌楸叶中分离出三种三萜糖苷。已确定糖苷的结构为 28-O-[α-L-吡喃鼠李糖基(1----4)-O-β-D-吡喃葡萄糖基(1----6)-be ta-D-吡喃葡萄糖苷3 alpha-hydroxy-lup-20(29)-ene-23,28-dioic acid, 3 alpha,11 alpha-dihydroxy-lup20(29)-ene-23,28-dioic acid and 3-epi-betulinic acid通过光谱数据和化学转化。最后两种化合物首次在植物界被发现。

  DOI：

  10.1016/0031-9422(91)83647-4

文献信息

• [EN] NOVEL C28-AMIDES WITH C3-MODIFICATIONS OF TRITERPENE DERIVATIVES AS HIV INHIBITORS<br/>[FR] NOUVEAUX AMIDES EN C28 AVEC DES MODIFICATIONS EN C3 DE DÉRIVÉS TRITERPÉNIQUES COMME INHIBITEURS DU VIH
  申请人：HETERO RESEARCH FOUNDATION

  公开号：WO2017025899A1

  公开（公告）日：2017-02-16

  Formula (I) The present invention relates to novel C28-amides with C3-modifications of triterpene compounds of formula (I); or pharmaceutically acceptable salts, pharmaceutically acceptable solvates, pharmaceutically acceptable hydrates, tautomers, stereoisomers, prodrugs or combination thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, X, and Y are as defined herein. The present invention also relates to pharmaceutical compositions comprising compounds of formula (I) useful for the therapeutic treatment of viral mediated diseases and particularly HIV mediated diseases.

  本发明涉及新型的C28酰胺，具有C3修饰的三萜化合物，其公式为(I)；或药用可接受的盐、药用可接受的溶剂化物、药用可接受的水合物、互变异构体、立体异构体、前药或它们的组合，其中R1、R2、R3、R4、R5、R6、R7、R8、R9、X和Y按本发明中定义。本发明还涉及包含公式(I)化合物的药物组合物，用于治疗病毒介导的疾病，特别是HIV介导的疾病。
• [EN] NOVEL BETULINIC SUBSTITUTED AMIDE DERIVATIVES AS HIV INHIBITORS<br/>[FR] NOUVEAUX DÉRIVÉS D'AMIDE SUBSTITUÉS BÉTULINIQUES UTILISÉS COMME INHIBITEURS DU VIH
  申请人：HETERO RESEARCH FOUNDATION

  公开号：WO2017017630A1

  公开（公告）日：2017-02-02

  The present invention relates to novel betulinic substituted amide compounds of formula (I); and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, X, Y, Z1, Z2, Z3 and are Formula (II) as defined herein. The invention novel betulinic substituted amide derivatives, related compounds, and pharmaceutical compositions useful for the therapeutic treatment of viral diseases and particularly HIV mediated diseases.

  本发明涉及新的取代苦杏仁酸酰胺化合物的化学式(I)；以及其药用盐，其中R1、R2、R3、R4、R5、R6、R7、R8、X、Y、Z1、Z2、Z3和在此定义的化学式(II)。该发明涉及新的取代苦杏仁酸酰胺衍生物、相关化合物和药物组合物，用于治疗病毒性疾病，特别是HIV介导的疾病。
• 23-Substituted Derivatives of Lupane-type Pentacyclic Triterpenoids
  申请人：Koohang Ali

  公开号：US20100144688A1

  公开（公告）日：2010-06-10

  The present invention comprises small molecule inhibitors of cell proliferative conditions, in particular cancer and conditions associated with cancer. For example, associated malignancies include ovarian cancer, cervical cancer, breast cancer, colorectal cancer, and glioblastomas, among others. Accordingly, the compounds of the present invention are useful for treating, preventing, and/or inhibiting these diseases. Thus, the present invention also comprises pharmaceutical formulations comprising the compounds and methods of using the compounds and formulations to inhibit cancer and treat, prevent, or inhibit the foregoing diseases.

  本发明包括针对细胞增殖病症的小分子抑制剂，特别是癌症及与癌症相关的病症。例如，相关的恶性肿瘤包括卵巢癌、宫颈癌、乳腺癌、结肠直肠癌和胶质母细胞瘤等。因此，本发明的化合物可用于治疗、预防和/或抑制这些疾病。因此，本发明还包括包含这些化合物的药物配方以及使用这些化合物和配方来抑制癌症并治疗、预防或抑制上述疾病的方法。
• Polynucleotide binding complexes comprising sterols and saponin
  申请人：Nordic Vaccine Technology A/S

  公开号：EP2011517A1

  公开（公告）日：2009-01-07

  The present invention pertains to complexes comprising sterols and saponins. The complexes are capable of binding a genetic determinant including a polynucleotide. The complexes may further comprise a lipophilic moiety, optionally a lipophilic moiety comprising a contacting group and/or a targeting ligand, and/or a saccharide moiety. The complexes may further comprise an immunogenic determinant and/or an antigenic determinant and/or a medicament and/or a diagnostic compound. The complexes may in even further embodiments be encapsulated by an encapsulation agent including a biodegradable microsphere. The present invention also pertains to pharmaceutical compositions and methods of treatment of an individual by therapy and/or surgery, methods of cosmetic treatment, and diagnostic methods practised on the human or animal body.

  本发明涉及由甾醇和皂甙组成的复合物。这些复合物能够结合包括多核苷酸在内的遗传决定因子。复合物可进一步包含亲脂分子，可选择包含接触基团和/或靶向配体的亲脂分子和/或糖分子。复合物可进一步包括免疫原决定簇和/或抗原决定簇和/或药物和/或诊断化合物。在更进一步的实施方案中，复合物可被包括生物可降解微球在内的封装剂封装。本发明还涉及通过治疗和/或手术对个体进行治疗的药物组合物和方法、美容治疗方法以及对人体或动物体进行诊断的方法。
• Synthesis and cytotoxic evaluation of novel ester-triazole-linked triterpenoid–AZT conjugates
  作者：Tuyet Anh Dang Thi、Nguyen Thi Kim Tuyet、Chinh Pham The、Ha Thanh Nguyen、Cham Ba Thi、Tien Doan Duy、Matthias D’hooghe、Tuyen Van Nguyen

  DOI：10.1016/j.bmcl.2014.09.079

  日期：2014.11

  Betulinic acid and analogous naturally occurring triterpenoid acids were transformed into the corresponding propargyl esters and subsequently deployed as substrates for a click chemistry-mediated coupling with azidothymidine (AZT) en route to novel 1,2,3-triazole-tethered triterpenoid-AZT conjugates. Twelve new hybrids were thus prepared and assessed in terms of their cytotoxic activity, revealing an interesting anticancer activity of five triterpenoid-AZT hybrids on KB and Hep-G2 tumor cell lines. (C) 2014 Elsevier Ltd. All rights reserved.